Lawrence M. Alleva - 16 Jun 2021 Form 4 Insider Report for Galera Therapeutics, Inc. (GRTX)

Role
Director
Signature
/s/ Christopher Degnan, Attorney-in-Fact for Lawrence M. Alleva
Issuer symbol
GRTX
Transactions as of
16 Jun 2021
Net transactions value
$0
Form type
4
Filing time
17 Jun 2021, 18:41:54 UTC
Previous filing
15 Jun 2021
Next filing
28 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRTX Stock Option (Right to Buy) Award $0 +9,888 $0.000000 9,888 16 Jun 2021 Common Stock 9,888 $8.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exercisable on the earlier of June 16, 2022 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date.